ELCC 2019 | The LUNAR study: TTFields for NSCLC

Ori Farber

Here Ori Farber, MD, of Novocure, Haifa, Israel, gives a background of the ongoing LUNAR study (NCT02973789) using tumor treating fields (TTF) to treat patients with non-small cell lung cancer (NSCLC) following progression while on or after platinum based treatment. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Share this video